Tick, tock, tick, tock. The countdown begins for tech behemoth Apple as it finds itself entangled in a legal battle that threatens to block the sale of its latest groundbreaking smartwatches. In a bold move, Apple has announced its intention to appeal a ruling by the U.S. International Trade Commission (ITC) which prohibits them from selling their Series 9 and Ultra 2 models. The dispute centers around the technology utilized by Apple's watches to measure blood oxygen levels, a light-based method that California-based company Massimo claims infringes upon their patented technology.
Before we dive into the nitty-gritty, let's recap what's been happening. Both Apple and Massimo have been grappling with this issue for years, with conflicting claims and counterclaims. However, in a landmark decision late last October, the ITC, an influential group advising the President and Congress, weighed in on the matter, ruling in favor of Massimo and concluding that Apple's use of the technology indeed violated their patents.
